{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:48:40Z","timestamp":1778320120283,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T00:00:00Z","timestamp":1509321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1404809"],"award-info":[{"award-number":["U1404809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571260"],"award-info":[{"award-number":["81571260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s10072-017-3171-7","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T01:02:08Z","timestamp":1509325328000},"page":"599-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A new target for the treatment of trigeminal neuralgia with botulinum toxin type A"],"prefix":"10.1007","volume":"39","author":[{"given":"Chuanjie","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanchang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6095-1313","authenticated-orcid":false,"given":"Yajun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,30]]},"reference":[{"key":"3171_CR1","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s10072-015-2382-z","volume":"36","author":"S Cesa La","year":"2015","unstructured":"La Cesa S, Tamburin S, Tugnoli V, Sandrini G, Paolucci S, Lacerenza M et al (2015) How to diagnose neuropathic pain? The contribution from clinical examination, pain questionnaires and diagnostic tests. Neurol Sci 36:2169\u20132175","journal-title":"Neurol Sci"},{"key":"3171_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10072-017-2892-y","volume":"38","author":"L Fariselli","year":"2017","unstructured":"Fariselli L, Ghielmetti F, Bosetti D, Franzini A, Marchetti M (2017) The role of radiosurgery in trigeminal neuralgia. Neurol Sci 38:63\u201365","journal-title":"Neurol Sci"},{"key":"3171_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s10194-017-0744-z","volume":"18","author":"G Sandrini","year":"2017","unstructured":"Sandrini G, De Icco R, Tassorelli C, Smania N, Tamburin S (2017) Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia. J Headache Pain 18:38","journal-title":"J Headache Pain"},{"key":"3171_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0333102412441721","volume":"32","author":"W CJ","year":"2012","unstructured":"CJ W, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC et al (2012) Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia 32:443\u2013450","journal-title":"Cephalalgia"},{"key":"3171_CR5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3109\/00207454.2015.1019624","volume":"126","author":"JH Xia","year":"2016","unstructured":"Xia JH, He CH, Zhang HF, Lian YJ, Chen Y, Wu CJ et al (2016) Botulinum toxin a in the treatment of trigeminal neuralgia. Int J Neurosci 126:348\u2013353","journal-title":"Int J Neurosci"},{"key":"3171_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1129-2377-15-65","volume":"15","author":"H Zhang","year":"2014","unstructured":"Zhang H, Lian Y, Ma Y, Chen Y, He C, Xie N et al (2014) Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial. J Headache Pain 15:65","journal-title":"J Headache Pain"},{"key":"3171_CR7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00002826-200209000-00006","volume":"25","author":"F Micheli","year":"2002","unstructured":"Micheli F, Scorticati MC, Raina G (2002) Beneficial effects of botulinum toxin type a for patients with painful tic convulsif. Clin Neuropharmacol 25:260\u2013262","journal-title":"Clin Neuropharmacol"},{"key":"3171_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1129-2377-15-43","volume":"15","author":"S Li","year":"2014","unstructured":"Li S, Lian YJ, Chen Y, Zhang HF, Ma YQ, He CH et al (2014) Therapeutic effect of botulinum toxin-a in 88 patients with trigeminal neuralgia with 14-month follow-up. J Headache Pain 15:43","journal-title":"J Headache Pain"},{"key":"3171_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1054\/jpai.2002.27142","volume":"3","author":"GE Borodic","year":"2002","unstructured":"Borodic GE, Acquadro MA (2002) The use of botulinum toxin for the treatment of chronic facial pain. J Pain 3:21\u201327","journal-title":"J Pain"},{"key":"3171_CR10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00002508-200503000-00010","volume":"21","author":"N Allam","year":"2005","unstructured":"Allam N, Brasil-Neto JP, Brown G, Tomaz C (2005) Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia. Clin J Pain 21:182\u2013184","journal-title":"Clin J Pain"},{"key":"3171_CR11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.wnf.0000172497.24770.b0","volume":"28","author":"U Turk","year":"2005","unstructured":"Turk U, Ilhan S, Alp R, Sur H (2005) Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol 28:161\u2013162","journal-title":"Clin Neuropharmacol"},{"key":"3171_CR12","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/01.wnl.0000180940.98815.74","volume":"65","author":"EJ Piovesan","year":"2005","unstructured":"Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD (2005) An open study of botulinum-a toxin treatment of trigeminal neuralgia. Neurology 65:1306\u20131308","journal-title":"Neurology"},{"key":"3171_CR13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/S0004-282X2008000400012","volume":"66","author":"C Zuniga","year":"2008","unstructured":"Zuniga C, Diaz S, Piedimonte F, Micheli F (2008) Beneficial effects of botulinum toxin type A in trigeminal neuralgia. Arq Neuropsiquiatr 66:500\u2013503","journal-title":"Arq Neuropsiquiatr"},{"key":"3171_CR14","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.tripleo.2009.03.021","volume":"109","author":"WC Ngeow","year":"2010","unstructured":"Ngeow WC, Nair R (2010) Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:e47\u2013e50","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"3171_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tripleo.2010.04.043","volume":"111","author":"B Bohluli","year":"2011","unstructured":"Bohluli B, Motamedi MH, Bagheri SC, Bayat M, Lassemi E, Navi F et al (2011) Use of botulinum toxin a for drug-refractory trigeminal neuralgia: preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111:47\u201350","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"3171_CR16","first-page":"117","volume":"23","author":"SY Wang","year":"2014","unstructured":"Wang SY, Yue J, YX X, Xue LF, Xiao WL, Zhang CY (2014) Preliminary report of botulinum toxin type A injection at trigger point for treatment of trigeminal neuralgia: experiences of 16 cases. Shanghai Kou Qiang Yi Xue = Shanghai J Stomatol 23:117\u2013119","journal-title":"Shanghai Kou Qiang Yi Xue = Shanghai J Stomatol"},{"key":"3171_CR17","first-page":"1994","volume":"95","author":"Y Xu","year":"2015","unstructured":"Xu Y, Zhang Q, Mao C, Hu W, Zhou X, Luo W (2015) Evaluation of therapeutic effectiveness and safety of botulinum toxin type A in the treatment of idiopathic trigeminal neuralgia in patients older than 70 years. Zhonghua Yi Xue Za Zhi 95:1994\u20131996","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"3171_CR18","doi-asserted-by":"publisher","unstructured":"Lunde HM, Torkildsen O, Bo L, Bertelsen AK (2016) Botulinum toxin as monotherapy in symptomatic trigeminal neuralgia. Headache 56(6):1035\u20131039. \nhttps:\/\/doi.org\/10.1111\/head.12791","DOI":"10.1111\/head.12791"},{"key":"3171_CR19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10072-017-2884-y","volume":"38","author":"C Lovati","year":"2017","unstructured":"Lovati C, Giani L (2017) Action mechanisms of Onabotulinum toxin-A: hints for selection of eligible patients. Neurol Sci 38:131\u2013140","journal-title":"Neurol Sci"},{"key":"3171_CR20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11916-017-0629-5","volume":"21","author":"K Meacham","year":"2017","unstructured":"Meacham K, Shepherd A, Mohapatra DP, Haroutounian S (2017) Neuropathic pain: central vs. peripheral mechanisms. Curr Pain Headache Rep 21:28","journal-title":"Curr Pain Headache Rep"},{"key":"3171_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","volume":"107","author":"M Cui","year":"2004","unstructured":"Cui M, Khanijou S, Rubino J, Aoki KR (2004) Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 107:125\u2013133","journal-title":"Pain"},{"key":"3171_CR22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/lary.24286","volume":"124","author":"E Guardiani","year":"2014","unstructured":"Guardiani E, Sadoughi B, Blitzer A, Sirois DA (2014) New treatment paradigm for trigeminal neuralgia using botulinum toxin type A. Laryngoscope 124:413\u2013417","journal-title":"Laryngoscope"},{"key":"3171_CR23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","volume":"186","author":"I Matak","year":"2011","unstructured":"Matak I, Bach-Rojecky L, Filipovic B, Lackovic Z (2011) Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience 186:201\u2013207","journal-title":"Neuroscience"},{"key":"3171_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s40064-016-2071-2","volume":"5","author":"C Wu","year":"2016","unstructured":"Wu C, Xie N, Lian Y, Xu H, Chen C, Zheng Y et al (2016) Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia. SpringerPlus 5:431","journal-title":"SpringerPlus"},{"key":"3171_CR25","first-page":"625","volume":"21","author":"W CJ","year":"2011","unstructured":"CJ W, Shen JH, Chen Y, Lian YJ (2011) Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm. Turk Neurosurg 21:625\u2013629","journal-title":"Turk Neurosurg"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-3171-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3171-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3171-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T01:25:29Z","timestamp":1521422729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-3171-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,30]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-3171-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,30]]}}}